Cargando…
Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590862/ https://www.ncbi.nlm.nih.gov/pubmed/34775967 http://dx.doi.org/10.1186/s13054-021-03816-x |
| _version_ | 1784599077402443776 |
|---|---|
| author | Zarbock, Alexander Chawla, Lakhmir Bellomo, Rinaldo |
| author_facet | Zarbock, Alexander Chawla, Lakhmir Bellomo, Rinaldo |
| author_sort | Zarbock, Alexander |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8590862 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85908622021-11-15 Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored Zarbock, Alexander Chawla, Lakhmir Bellomo, Rinaldo Crit Care Commentary BioMed Central 2021-11-14 /pmc/articles/PMC8590862/ /pubmed/34775967 http://dx.doi.org/10.1186/s13054-021-03816-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Commentary Zarbock, Alexander Chawla, Lakhmir Bellomo, Rinaldo Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored |
| title | Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored |
| title_full | Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored |
| title_fullStr | Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored |
| title_full_unstemmed | Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored |
| title_short | Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored |
| title_sort | why the renin–angiotensin–aldosterone system (raas) in critically ill patients can no longer be ignored |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590862/ https://www.ncbi.nlm.nih.gov/pubmed/34775967 http://dx.doi.org/10.1186/s13054-021-03816-x |
| work_keys_str_mv | AT zarbockalexander whythereninangiotensinaldosteronesystemraasincriticallyillpatientscannolongerbeignored AT chawlalakhmir whythereninangiotensinaldosteronesystemraasincriticallyillpatientscannolongerbeignored AT bellomorinaldo whythereninangiotensinaldosteronesystemraasincriticallyillpatientscannolongerbeignored |